DrugPatentWatch Database Preview

Details for Patent: 8,137,993

« Back to Dashboard

Which drugs does patent 8,137,993 protect, and when does it expire?

Patent 8,137,993 protects CYCLOSET and is included in one NDA.

Summary for Patent: 8,137,993

Title:	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
Abstract:	The present invention is directed to a method of identifying patients to be treated by dopamine agonist therapy comprising the step of analyzing a plasma or urine sample from said patient for concentrations of norepinephrine (NE), norepinephrine metabolites (NE metabolites), dopamine, dopamine metabolites, serotonin, serotonin metabolites, or fasting triglycerides, wherein one or more of: (a) NE metabolites, (b) NE/NE metabolites: dopamine/dopamine metabolites, (c) NE and serotonin, (d) NE/NE metabolites and serotonin, (e) NE and serotonin metabolites, (f) NE/NE metabolites and serotonin metabolites, or (g) NE is/are greater than about 30% over normal level; or dopamine/dopamine metabolites are less than about 30% below normal; or fasting triglycerides are greater than about 150 mg/dl and/or said patient has hypertension. The present invention is also directed to treating identified patients with dopamine agonist therapy.
Inventor(s):	Cincotta; Anthony H. (Tiverton, RI)
Assignee:	VeroScience LLC (Tiverton, RI)
Application Number:	13/066,255
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,137,993

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes